Carna Biosciences, Inc. (TYO:4572)
Japan flag Japan · Delayed Price · Currency is JPY
221.00
-6.00 (-2.64%)
Aug 28, 2025, 3:30 PM JST

Carna Biosciences Revenue

Carna Biosciences had revenue of 107.65M JPY in the quarter ending June 30, 2025, a decrease of -20.26%. This brings the company's revenue in the last twelve months to 572.00M, down -60.28% year-over-year. In the year 2024, Carna Biosciences had annual revenue of 636.00M, down -60.86%.

Revenue (ttm)
572.00M
Revenue Growth
-60.28%
P/S Ratio
7.58
Revenue / Employee
9.08M
Employees
63
Market Cap
4.34B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024636.00M-989.00M-60.86%
Dec 31, 20231.63B239.00M17.24%
Dec 31, 20221.39B-631.00M-31.28%
Dec 31, 20212.02B884.00M78.02%
Dec 31, 20201.13B-2.07B-64.67%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Chugai Pharmaceutical1,196.21B
Takeda Pharmaceutical Company4,480.25B
Daiichi Sankyo Company1,924.68B
HOYA Corporation876.09B
Otsuka Holdings2,401.70B
Terumo1,037.94B
Astellas Pharma1,944.99B
Shionogi &440.50B
Revenue Rankings